Several of the nation’s largest cannabis companies are curtailing retail expansion plans for 2024, a consequence of licensing caps, limited new market opportunities and ongoing capital concerns.
Those realities will curb expansion in several states this year as numerous multistate operators focus on core business lines rather than increasing operational expenses, industry sources told MJBizDaily.
ADVERTISEMENT
Despite the hurdles, some legal U.S. markets are projected to increase the number of marijuana retailers significantly.
MSOs this year are expected to add dozens of new adult-use stores in Ohio, largely thanks to a 2023 voter-approved ballot initiative that prioritized expansion for existing medical cannabis operators.
In New York, a handful of vertically integrated MSOs – The Cannabist Co., Curaleaf Holdings and PharmaCann, for starters – received
Read full article on Marijuana Business Daily
